Pulmatrix merger with Eos SENOLYTIX expected to close by year-end
Story updates
01:06:03 PM UTC
SquawkNews
Pulmatrix said its merger with Eos SENOLYTIX is anticipated to close in November, subject to Nasdaq listing approval, a reverse stock split and other customary conditions. Q3 cash and equivalents were $1.4M, versus $4.1M at Dec. 31, 2025; the company cited going-concern uncertainty.Material Details…
01:07:12 PM UTC
SquawkNews
Pulmatrix Anticipates Cash Position Sufficient to Fund Ops at Least Through Anticipated Closing of Proposed Merger